Discover Great Companies Discover Great Clients
Popularity  46.4万   |   Followers  556   |   Likes  85   |   Feedback  657 Claim this company

Mainly engaged in the production and sales of antibiotics, traditional

No.20 Hangzhou City Popularity Ranking No.2 Gongshu District No.34 Zhejiang P No.1 Sheng Wu Ji Materials No.1 Chinese Medicinal Materials No.1 Compositing Biotechnology No.1 Materials R&D No.1 Yuan Yan Yao No.1 Pharmaceutical APIs No.1 Ren Yong Yi Miao No.1 Vaccines No.1 Materials Technology No.1 Chemistry Pharmaceuticals No.1 Peptides No.1 Jian Kang Chan Industries 国家科技进步奖 发明专利 创新型企业 知识产权示范企业 知识产权优势企业 国家高新技术企业 COS认证 ISO14001认证 GMP认证
More

Company Overview

  • Nature: Listed Company Size: 10,000+ employees Founded: 34年
  • Industry: Pharmaceutical/Bioengineering 、 Raw Material Processing 、 Medical Equipment/Devices
  • Full name: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.。

Development Stage

  • Ranking: Ranked #20 in Hangzhou City by popularity Ranked #1 in Hangzhou Sheng Wu Ji Materials Company by popularity Ranked #1 in Hangzhou Chinese Medicinal Materials Company by popularity Ranked #1 in Hangzhou Compositing Biotechnology Company by popularity Ranked #1 in Hangzhou Materials R&D Company by popularity
  • Honors: 2023中国中成药企业100强 国家科技进步奖 发明专利 According to algorithm
  • Salary: 57.2% of positions earn 8-15K, In 2026 vs last yearremained flat.。Master's salary: ¥18.6K, Doctorate salary: ¥28.3K.
  • R&D: "Medical & Health/Beauty & Healthcare" demand: 45.1%, "Computer/Network/Technology": 6.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 4.9%。
  • Recruiting: In 2026 vs 2025decreased by 16%. Demand for highly educated talent: Master's: 81, Doctorate: 14.
  • Requirement: Education: 本科 leads with 61.4%. Experience: 1-3年 leads with 51.5%.
  • Region: Distributed across 66 regions, 杭州: 14.6%, 长沙: 2.8%, 重庆: 2.7%, 西安: 2.4%.

About the Company

[Summary] Mainly engaged in the production and sales of antibiotics, traditional

Huadong Medicine Co., Ltd. (stock code: 000963) was founded in 1993, headquartered in Hangzhou, Zhejiang, and listed on the Shenzhen Stock Exchange in December 1999. After more than 30 years of development, the company's business covers the entire pharmaceutical industry chain, with four major business segments: pharmaceutical industry, pharmaceutical distribution, medical aesthetics, and industrial microbiology. It has grown into a large comprehensive pharmaceutical listed company integrating innovative drug R&D, production, and distribution. The pharmaceutical industry segment focuses on the R&D, production, and sales of drugs for specialized treatments, chronic diseases, and special medications, with a complete manufacturing system oriented to international standards, forming core product lines in chronic kidney disease, immunology, oncology, endocrinology, digestive system, and cardiovascular diseases, among others. It holds multiple first-line clinical drugs with market advantages in China, and several products have obtained international registration certifications. Through independent development, external introduction, and project cooperation, the company strategically focuses its innovative drug R&D on three core therapeutic areas: endocrinology, autoimmune diseases, and oncology, building a differentiated innovative drug pipeline covering the entire R&D cycle and a well-structured product portfolio. The pharmaceutical distribution segment focuses on three core sectors: pharmaceuticals, medical devices, and herbal decoction pieces. Anchored by an intelligent logistics network, it strengthens competitiveness through specialized logistics for cold chain, special drugs, and vaccines, and its business scale consistently ranks first in Zhejiang Province. The pharmaceutical sector boasts comprehensive advantages including full product coverage, full-channel connectivity, efficient coordination between hospital and non-hospital channels, and deep synergy between distribution and agency. The medical device sector relies on a large-scale distribution network to support professional agency services, focusing on innovative businesses. The herbal decoction pieces sector has advantages across the entire industry chain, continuing to expand its provincial business through upgrades, efficiency improvements, and capacity expansion. Driven by digitalization and innovative services as core engines, the company builds a "comprehensive pharmaceutical service" ecosystem by integrating CSO cooperation, SPD supply chain management, and industry-academia-research projects, precisely linking upstream and downstream needs. Meanwhile, it focuses on three strategic pillars: organizational efficiency, cost control, and regional deepening, to continuously consolidate its industry position. The medical aesthetics segment aims to become a "top global medical aesthetics enterprise," adhering to the strategy of "globalized operations and dual-cycle business development." With international vision and forward-looking planning, it creates a comprehensive and differentiated product matrix, with product quantity and application areas ranking among the industry's forefront. It integrates "non-invasive + minimally invasive" technologies, "facial + body" areas, and "injection + energy-based devices" dimensions, achieving full coverage of regenerative products, hyaluronic acid, and botulinum toxin in injectables, forming a differentiated pipeline. It provides more professional, safe, efficient, and comprehensive solutions for beauty seekers, committed to becoming a top global provider of comprehensive medical aesthetic solutions. The industrial microbiology segment focuses on two strategic directions: synthetic biology technology innovation and biopharmaceutical industry upgrading, prioritizing four core business sectors: xRNA raw materials, specialty APIs & intermediates, health & biomaterials, and animal health.

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (617 open positions)

Manage
?
Growth Rate
2026 vs 2025
  • 2025: Up 65%
  • 2024: Up 84%
  • 2023: Up 78%
  • 2022: Down 55%
Year-by-Year Hiring:
* Hiring was generally low during 2020-2022 due to the pandemic
Campus Recruitment & Advanced Degree Talent Demand
Graduates 7 Interns 9 Master's 81 Doctorate 14
No.88
Company Recruitment Ranking in Hangzhou City 򀀩
No.3431
Recruitment Growth Ranking in Hangzhou City 򀀩
No.62
Graduate Talent Ranking in Hangzhou City 򀀩
No.31
Intern Talent Ranking in Hangzhou City 򀀩
Note: How fast is hiring at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. growing? 2026: 2114 openings (down 16%), 2025: 2524 openings (up 65%), 2024: 1532 openings (up 84%), 2023: 831 openings (up 78%), 2022: 468 openings (down 55%), 2021: 1039 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 55%
  • 2024: Up 56%
  • 2023: Up 580%
  • 2022: Down 47%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. growing? Master's recruitment over the years: 2025: 164 openings (up 55%), 2024: 106 openings (up 56%), 2023: 68 openings (up 580%), 2022: 10 openings (down 47%), 2021: 19 openings. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. master talent ranking in Hangzhou: #15, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. master salary mostly around 8-15K.

Doctoral Degree Job Demand Analysis

(More)
+144%
Growth Rate
2026 vs 2025
  • 2025: Up 29%
  • 2024: Up 75%
  • 2023: Up 300%
  • 2022: Down 75%
Doctoral Hiring by Year: 2026 — 13 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. growing? Doctorate recruitment over the years: 2026: 22 openings (up 144%), 2025: 9 openings (up 29%), 2024: 7 openings (up 75%), 2023: 4 openings (up 300%), 2022: 1 openings (down 75%), 2021: 4 openings. Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. doctorate talent ranking in Hangzhou: #20, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. doctorate salary mostly around 20-50K.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.? Based on an analysis of 's job postings over the past year, "Medical & Health/Beauty & Healthcare" demand: 45.1%, "Computer/Network/Technology": 6.6%, "Biology/Pharmaceutical/Chemical/Environmental Protection": 4.9%, "Other (R&D and Technical)": 2.5%, "Scientific Research": 2%, "Electrical/Energy/Power": 0.8%. For reference only.

— What Are the Salaries Like? (1125 records)

Manage
salary range: 4.5K - 50K, 57.2% of roles pay ¥8-15K
Note: salary statistics are based on 1125 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.?57.2% of positions earn 8-15K, Fresh graduate salary: ¥5.3K。Hangzhou salary ranking: #3136,医疗卫生/美容保健类 average salary ¥12.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.? We provide: 药学, Service Specialist, Pharmaceutical Sales Representative, Promotion Specialist, Sales, Information, 临床, Marketing, 医学专员, Intern, Academic Specialist, Key Account Manager, Researcher, OTC Representative, Analyst, Medical Manager, Regional Manager, Security Officer, QC, Production Worker. Click to view detailed salary analysis by job.

This company — Fortune 500? (More)

Yes, ranked in 中国中成药企业100强:

  • NO.45 2023中国中成药企业100强 >
  • NO.9 2022中国中成药企业100强 >

Job Category

  • 医疗卫生/美容保健类
    47.5% of total 47.5%
  • 销售类
    37.6% of total 37.6%
  • 市场/公关/媒介类
    12.4% of total 12.4%
  • 经营管理类
    8.4% of total 8.4%

Education

  • 本科
    61.4% of total 61.4%
  • 大专
    26.6% of total 26.6%
  • 硕士
    9.3% of total 9.3%
  • 不限
    1.6% of total 1.6%

Experience

  • 1-3年
    51.5% of total 51.5%
  • 不限
    31.9% of total 31.9%
  • 3-5年
    11.8% of total 11.8%
  • 5-10年
    4.2% of total 4.2%
View Detailed Analysis

What does Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. require? Who is Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. hiring? recruitment: 医疗卫生/美容保健类占比最多占47.5%,其次是销售类占37.6%. What education can get in at ? 本科占比最多占61.4%,其次是大专占26.6%. High education required at ? 硕士占9.3%,博士占0.9%. Work experience required at ? 1-3年占比最多占51.5%,其次是不限占31.9%. Where are the job locations at ? 杭州占比最多占14.6%,其次是长沙占2.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 87,230.813万(元)
Legal Representative: 秦祥田
Date Established:
Credit Code: 91330100609120774J
Registered Address: 浙江省杭州市拱墅区莫干山路866号祥符桥

Partners & Suppliers

中美华东制药作为华东医药子公司,向杭州华东大药房供应化学药品。 Source
合作客户 药品生产(化学药)
华东医药供应链管理(杭州)有限公司为其提供药品仓储及物流配送服务 Source
供应商 医药生产商
2022年,华东医药与科济药业达成合作,获得泽沃基奥仑赛注射液(BCMA CAR-T)在中国大陆的独家商业化权益。 Source
供应商 细胞治疗
重庆皓元为华东医药提供原料药及中间体CDMO服务 Source
供应商 CDMO服务客户
诚达药业向中美华东提供CDMO服务,合作涉及多个创新药中间体的研发与供应 Source
供应商 CDMO客户

People who follow this company also follow

Competitors (Similar Companies)

“Mainly engaged in the production and sales of antibiotics, traditional”
“A provincial high-tech enterprise specializing in the development, pro”
“Professional services for the entire clinical trial process of drug pr”
“Is an innovative filtration enterprise, focusing on the development an”
“Research, development, and production of anti-tumor and surgical medic”
“Continuously innovating to bring patients medicines that significantly”
“A renowned enterprise in China's liver disease and anti-tumor fields”
“To develop high-quality biologics that are accessible and affordable f”
“To produce more affordable and effective medicines for the Chinese peo”
“A high-tech enterprise dedicated to the research, development, and ind”
“Top 10 in China's beverage industry”
“Accelerating global biologic drug R&D processes, reducing R&D costs, a”
“Seek and strive, protect and heal all beings”
“One of the leading enterprises in the pharmaceutical industry”
“The first third-party medical diagnostic institution listed in China”

Discover Great Companies, Discover Great Clients

杭州公司名录 杭州“Gongshu District”公司名录 杭州“医药”公司名录 杭州“中成药”公司名录 杭州“原料药”公司名录 杭州“生物制品”公司名录 杭州“生物科技/生物工程”公司名录 附近的公司

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates